BridgeMD
Tests treatment safety and results for Hypertension
Official title Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal
ClinicalTrials.gov ID: NCT05979168
What this study is testing
- What it's testing
- Despite evidence of preventing cardiovascular disease (CVD) risk through lifestyle changes, many patients with hypertension (HTN) do not comply with this and suffer from CVD and other complications. A previous study using a structured lifestyle intervention program has reported a 14% decrease in the 10-year risk of developing CVD at one year among hypertensive and diabetes patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Clinical diagnosis of hypertension
- Currently receiving/prescribed blood pressure-lowering medication for more than three months
- With uncontrolled blood pressure (\>130/80mm of Hg)
- Should have access to a mobile phone
- Able to read text messages ( by themselves/with the help of family)
You likely can't join if
- Diagnosed with myocardial infarction, stroke, and kidney failure
- Severe mental illness, cognitive impairment
- Pregnant women or in the postpartum period
The study team makes the final eligibility decision.
Where it's taking place
- Kathmandu, Bagmati, Nepal
- Kathmandu, Pradesh 3 (Bagmati), Nepal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kathmandu, Bagmati, Nepal; Kathmandu, Pradesh 3 (Bagmati), Nepal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.